<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02568735</url>
  </required_header>
  <id_info>
    <org_study_id>KUH30062008</org_study_id>
    <nct_id>NCT02568735</nct_id>
  </id_info>
  <brief_title>Dexketoprofen and Etoricoxib in Patients Undergoing Hip Arthroplasty</brief_title>
  <acronym>etoketo</acronym>
  <official_title>The Central Nervous Penetration of Dexketoprofen and Etoricoxib and Their Effect on Pain and Inflammatory Reaction in Patients Undergoing Hip Arthroplasty</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Kuopio University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Kuopio University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study was to determine the plasma and central nervious system
      pharmacokinetics of dexketoprofen and etoricoxib. The secondary aim was to asses their effect
      on the concentrations of interleukin 6, prostaglandin E2 and other proinflammatory markers
      both in plasma and cerebrospinal fluid. Thirdly, the investigators aimed to evaluate their
      efficacy in postoperative pain treatment.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2013</start_date>
  <completion_date type="Actual">December 2014</completion_date>
  <primary_completion_date type="Actual">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cerebrospinal fluid concentration dexketoprofen and etoricoxib</measure>
    <time_frame>0-24 hours</time_frame>
    <description>Cerebrospinal fluid concentration of dexketoprofen and etoricoxib</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma concentration dexketoprofen and etoricoxib</measure>
    <time_frame>0-24 hours</time_frame>
    <description>Plasma concentration dexketoprofen and etoricoxib</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain</measure>
    <time_frame>0-24 h</time_frame>
    <description>Pain assessed with numeral rating scale</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">24</enrollment>
  <condition>Pain, Postoperative</condition>
  <arm_group>
    <arm_group_label>Etoricoxib</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Etoricoxib 60mg if body weightâ‰¤ 60kg, 90mg if body weight 61-90kg and 120mg if body weight&gt; 90kg by mouth</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dexketoprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Dexketoprofen 0,5 mg/kg up to 50 mg intravenously</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexketoprofen</intervention_name>
    <description>After total hip replacement surgery patient were given either etoricoxib or dexketoprofen</description>
    <arm_group_label>Dexketoprofen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Etoricoxib</intervention_name>
    <description>After total hip replacement surgery patient were given either etoricoxib or dexketoprofen</description>
    <arm_group_label>Etoricoxib</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  agreed to participate the study

          -  American Society of Anesthesiologist s physical status classification 1-3

          -  elective hip arthroplasty planned

          -  no contraindications to the study drugs

          -  no contraindication to lumbar puncture

        Exclusion Criteria:

          -  refused to participate the study

          -  age less than 40 or over 75 years

          -  Planned anesthesia method other than spinal anesthesia

          -  contraindications to the study drugs

          -  Contraindications to lumbar puncture
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 5, 2015</study_first_submitted>
  <study_first_submitted_qc>October 5, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 6, 2015</study_first_posted>
  <last_update_submitted>April 30, 2016</last_update_submitted>
  <last_update_submitted_qc>April 30, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 3, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Kuopio University Hospital</investigator_affiliation>
    <investigator_full_name>Merja Kokki</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Dexketoprofen</keyword>
  <keyword>Etoricoxib</keyword>
  <keyword>hip arthroplasty</keyword>
  <keyword>pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pain, Postoperative</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Etoricoxib</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <pending_results>
    <submitted>April 11, 2017</submitted>
    <returned>May 15, 2017</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

